Minimum Requirements for Reporting Fecal Microbiota Transplant Trial
نویسندگان
چکیده
1. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran 2. Division of Digestive Diseases, Rush University Medical Center, Chicago, IL, USA 3. Gastroenterology & Oncology, Henri Mondor Hospital and University Paris-Est CRETEIL (UPEC), Paris, France Shirin Moossavi1, Faraz Bishehsari2, Reza Ansari1, Homayoon Vahedi1, Siavosh Nasseri-Moghaddam1, Shahin Merat1, Iradj Sobhani3, Ali Keshavarzian2, Reza Malekzadeh1*
منابع مشابه
TREATMENT OF OBESITY BY IMPROVING THE METABOLISM OF OBESE PEOPLE BY FECAL MICROBIOTA TRANSPLANTATION (FMT) AND FECAL CAPSULES (SYSTEMATIC REVIEW)
Background: Over the past half-century, the prevalence of obesity and related metabolic disorders such as fat disorders, cardiovascular disease, myocardial infarction and stroke have increased dramatically. Various types of organisms, including bacteria, fungi, protozoan, and viruses, have evolved to live in the human gut, called microbiota. Scientists have found that thin people have a balance...
متن کاملClostridium difficile Infection and Fecal Microbiota Transplant.
Clostridium difficile infection (CDI) is a major source of morbidity and mortality for hospitalized patients. Although most patients have a clinical response to existing antimicrobial therapies, recurrent infection develops in up to 30% of patients. Fecal microbiota transplant is a novel approach to this complex problem, with an efficacy rate of nearly 90% in the setting of multiple recurrent C...
متن کاملLoss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
We report the use of fecal microbiota transplantation in a single heart-kidney transplant recipient with recurrent Clostridium difficile, vancomycin-resistant Enterococcus (VRE) fecal dominance, and recurrent VRE infections. Fecal microbiota transplantation resulted in the reconstruction of a diverse microbiota with (1) reduced relative abundance of C difficile and VRE and (2) positive clinical...
متن کاملDesigning fecal microbiota transplant trials that account for differences in donor stool efficacy.
Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile, a common hospital-acquired infection. Fecal microbiota transplantation's success as a therapy for C. difficile has inspired interest in performing clinical trials that experiment with fecal microbiota transplantation as a therapy for other conditions like inflammatory...
متن کاملFecal microbiota transplant to treat recurrent Clostridium difficile infections.
The prevalence of recurrent or refractory Clostridium difficile infection has been steadily increasing since 2000. Consequently, alternative treatments to the standard antibiotic therapies are now being considered. One alternative treatment is fecal microbiota transplant. Although fecal microbiota transplant is relatively new--and not appealing to most people--it has been around for many years ...
متن کامل